OS05.2.A <i>MGMT</i> promoter status in <i>IDH1/2</i> mutant anaplastic astrocytoma patients assessed by DNA methylation profiling and qMS-PCR: a report from the EORTC Brain Tumor Group

Authors: C M S Tesileanu, P J French, M Sanson, A A Brandes, W Wick, P M Clement, J M Kros, T Gorlia, V Golfinopoulos, M J van den Bent

Published: 2021-09-09

DOI: 10.1093/neuonc/noab180.019

Source: Full article


Abstract

Abstract